GILEAD SCIENCES, INC

GILD
Delayed Quote. Delayed  - 09/23 04:00:01 pm
62.86USD -1.43%
Valuation
Fiscal Period: December 2021 2022
Capitalization1 91 08178 787
Enterprise Value (EV)1 118 53095 059
P/E ratio 14,7x20,1x
Yield 3,91%4,64%
Capitalization / Revenue 3,34x3,13x
EV / Revenue 4,34x3,77x
EV / EBITDA 8,12x7,26x
Price to Book 4,32x3,64x
Nbr of stocks (in thousands) 1 254 3841 253 367
Reference price (USD) 72,662,9
Announcement Date 02/01/2022-
Previous period Next period
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2021 2022
Net sales1 27 30525 204
EBITDA1 14 59813 102
Operating profit (EBIT)1 12 54811 323
Operating Margin 46,0%44,9%
Pre-Tax Profit (EBT)1 8 2784 715
Net income1 6 2253 837
Net margin 22,8%15,2%
EPS2 4,933,13
Dividend per Share2 2,842,92
Announcement Date 02/01/2022-
Previous period Next period
1 USD in Million
2 USD
Estimates
Finances - Leverage
Fiscal Period: December 2021 2022
Net Debt1 27 44916 272
Net Cash position1 --
Leverage (Debt / EBITDA) 1,88x1,24x
Free Cash Flow1 10 8057 176
ROE (Net Profit / Equities) 46,8%37,7%
Shareholders' equity1 13 30510 165
ROA (Net Profit / Asset) 9,13%9,26%
Assets1 68 18041 457
Book Value Per Share2 16,817,3
Cash Flow per Share2 9,027,86
Capex1 579709
Capex / Sales 2,12%2,81%
Announcement Date 02/01/2022-
Previous period Next period
1 USD in Million
2 USD
Estimates
Financial Ratios
Size 2022e 2023e
Capitalization 78 787 M $ -
Enterprise Value (EV) 95 059 M $ 92 251 M $
Valuation 2022e 2023e
P/E ratio (Price / EPS) 20,1x 13,9x
Capitalization / Revenue 3,13x 3,20x
EV / Revenue 3,77x 3,86x
EV / EBITDA 7,26x 7,65x
Yield (DPS / Price) 4,64% 4,83%
Price to book (Price / BVPS) 3,64x 3,28x
Profitability 2022e 2023e
Operating Margin (EBIT / Sales) 44,9% 43,6%
Operating Leverage (Delta EBIT / Delta Sales) -1,27x -2,23x
Net Margin (Net Profit / Revenue) 15,2% 23,1%
ROA (Net Profit / Asset) 9,26% 7,62%
ROE (Net Profit / Equities) 37,7% 29,8%
Rate of Dividend 93,1% 67,0%
Balance Sheet Analysis 2022e 2023e
CAPEX / Sales   2,81% 2,72%
Cash Flow / CA 39,1% 33,1%
Capital Intensity (Assets / Revenue) 1,64x 3,03x
Financial Leverage (Net Debt / EBITDA) 1,24x 1,08x
Price Earning Ratio
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS & Dividend